Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06411600
Title Combination Therapy for BRAF-V600E Metastatic CRCm (BRAVE)
Acronym BRAVE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Vall d'Hebron Institute of Oncology
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Additional content available in CKB BOOST